Teng Hou

1.1k total citations
41 papers, 861 citations indexed

About

Teng Hou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Teng Hou has authored 41 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Teng Hou's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Teng Hou is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Teng Hou collaborates with scholars based in China, Burundi and United Kingdom. Teng Hou's co-authors include Gallina Kazobinka, Xin Huang, Xinran Zhao, Yu‐Wen Alvin Huang, Jing‐Song Ou, Zhaohui Chen, Weijing Zhang, Ming Xiong, Liang Chen and Yanna Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and ACS Applied Materials & Interfaces.

In The Last Decade

Teng Hou

40 papers receiving 856 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teng Hou China	17	525	319	130	99	78	41	861
Piao Huang China	7	542 1.0×	435 1.4×	140 1.1×	144 1.5×	85 1.1×	13	887
Qin‐Sheng Mao China	17	499 1.0×	364 1.1×	119 0.9×	30 0.3×	109 1.4×	43	861
Yong Zhu China	19	758 1.4×	258 0.8×	152 1.2×	123 1.2×	106 1.4×	39	1.1k
Fangwei Xie China	15	367 0.7×	165 0.5×	265 2.0×	105 1.1×	49 0.6×	26	695
Xinmiao Yu China	18	436 0.8×	258 0.8×	168 1.3×	59 0.6×	135 1.7×	61	943
Jinqiu Tao China	14	507 1.0×	319 1.0×	174 1.3×	64 0.6×	93 1.2×	36	841
Huijie Gao China	20	487 0.9×	301 0.9×	309 2.4×	95 1.0×	93 1.2×	59	1.1k
Yichao Wang China	14	369 0.7×	178 0.6×	67 0.5×	188 1.9×	39 0.5×	39	675
Gongwei Wu China	15	814 1.6×	474 1.5×	209 1.6×	189 1.9×	112 1.4×	17	1.3k
Xiaocen Liu China	13	367 0.7×	253 0.8×	67 0.5×	104 1.1×	177 2.3×	32	732

Countries citing papers authored by Teng Hou

Since Specialization

Citations

This map shows the geographic impact of Teng Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teng Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teng Hou more than expected).

Fields of papers citing papers by Teng Hou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teng Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teng Hou. The network helps show where Teng Hou may publish in the future.

Co-authorship network of co-authors of Teng Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Teng Hou. A scholar is included among the top collaborators of Teng Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teng Hou. Teng Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Han, Xiaomin, Ming Xiong, Yajun Xiao, et al.. (2025). Single-position intraperitoneal laparoscopic radical nephroureterectomy using a modified supine position. BMC Urology. 25(1). 296–296.

Hou, Teng, et al.. (2024). UHRF1-mediated ubiquitination of nonhomologous end joining factor XLF promotes DNA repair in human tumor cells. Journal of Biological Chemistry. 300(11). 107823–107823. 1 indexed citations

Chen, Liang, Wei Dong, Chenlu Yang, et al.. (2023). PABPN1 regulates mRNA alternative polyadenylation to inhibit bladder cancer progression. Cell & Bioscience. 13(1). 45–45. 8 indexed citations

Xiong, Ming, et al.. (2023). Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma. Translational Andrology and Urology. 12(4). 533–548. 1 indexed citations

Chen, Liang, Yarong Song, Teng Hou, et al.. (2022). Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism. Journal of Experimental & Clinical Cancer Research. 41(1). 194–194. 36 indexed citations

Hou, Teng, Liang Chen, Ming Xiong, et al.. (2022). Comprehensive analysis of lower mitochondrial complex I expression is associated with cell metastasis of clear cell renal cell carcinoma. Translational Cancer Research. 11(6). 1488–1502. 4 indexed citations

Xiong, Ming, Wencheng Li, Longwang Wang, et al.. (2022). Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer. BMC Cancer. 22(1). 1026–1026. 6 indexed citations

Chen, Liang, Wencheng Li, Zhiqin Li, et al.. (2021). circNUDT21 promotes bladder cancer progression by modulating the miR-16-1-3p/MDM2/p53 axis. Molecular Therapy — Nucleic Acids. 26. 625–636. 13 indexed citations

Xing, Yifei, Liang Chen, Haifeng Gu, et al.. (2021). Downregulation of NUDT21 contributes to cervical cancer progression through alternative polyadenylation. Oncogene. 40(11). 2051–2064. 23 indexed citations

10.

Hou, Teng, Weiwei Mu, Rui Yang, et al.. (2020). Nanoparticle-Loaded Polarized-Macrophages for Enhanced Tumor Targeting and Cell-Chemotherapy. Nano-Micro Letters. 13(1). 6–6. 51 indexed citations

11.

Wang, Tianqi, Weiwei Mu, Feifei Li, et al.. (2020). “Layer peeling” co-delivery system for enhanced RNA interference-based tumor associated macrophages-specific chemoimmunotherapy. Nanoscale. 12(32). 16851–16863. 12 indexed citations

12.

Xiong, Ming, Liang Chen, Lijie Zhou, et al.. (2019). NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation. Theranostics. 9(24). 7156–7167. 48 indexed citations

13.

Chen, Zhaohui, Lijie Zhou, Xuehan Liu, et al.. (2018). Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway. Laboratory Investigation. 98(9). 1225–1236. 5 indexed citations

14.

Hou, Teng, et al.. (2018). Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway. Cellular Physiology and Biochemistry. 47(6). 2250–2260. 24 indexed citations

15.

Zhang, Weijing, Longwang Wang, Gallina Kazobinka, et al.. (2016). Musashi-2 promotes migration and invasion in bladder cancer via activation of the JAK2/STAT3 pathway. Laboratory Investigation. 96(9). 950–958. 54 indexed citations

16.

Xiao, Juan, et al.. (2015). Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling. Molecular Medicine Reports. 12(3). 3249–3256. 29 indexed citations

17.

Zhang, Weijing, Weiling He, Teng Hou, et al.. (2015). Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Tumor Biology. 37(5). 6239–6254. 26 indexed citations

18.

Hou, Teng, Weijing Zhang, Gallina Kazobinka, et al.. (2015). Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome. BMC Cancer. 15(1). 785–785. 51 indexed citations

19.

Hou, Teng, et al.. (2014). MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. British Journal of Cancer. 110(5). 1260–1268. 122 indexed citations

20.

Zhang, Lan, He Huang, Longjuan Zhang, et al.. (2014). URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer. BMC Cancer. 14(1). 885–885. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact